Revolve Wealth Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$421K Buy
6,253
+9
+0.1% +$600 0.04% 218
2026
Q1
$392K Buy
6,244
+171
+3% +$11.9K 0.05% 151
2025
Q4
$403K Buy
6,073
+49
+0.8% +$3.17K 0.05% 154
2025
Q3
$405K Buy
6,024
+38
+0.6% +$3.01K 0.05% 144
2025
Q2
$523K Sell
5,986
-238
-4% -$18.7K 0.07% 123
2025
Q1
$425K Buy
6,224
+3
+0% +$245 0.06% 133
2024
Q4
$484K Sell
6,221
-419
-6% -$31K 0.07% 126
2024
Q3
$445K Buy
6,640
+4,495
+210% +$369K 0.07% 123
2024
Q2
$243K Sell
2,145
-70
-3% -$8.85K 0.04% 154
2024
Q1
$307K Buy
2,215
+69
+3% +$8.67K 0.05% 129
2023
Q4
$266K Sell
2,146
-136
-6% -$13.9K 0.05% 132
2023
Q3
$213K Sell
2,282
-164
-7% -$18.5K 0.05% 137
2023
Q2
$314K Buy
2,446
+118
+5% +$14.3K 0.07% 109
2023
Q1
$270K Sell
2,328
-178
-7% -$19.9K 0.07% 117
2022
Q4
$284K Sell
2,506
-204
-8% -$22.4K 0.08% 111
2022
Q3
$218K Sell
2,710
-161
-6% -$13.6K 0.07% 115
2022
Q2
$214K Buy
2,871
+43
+2% +$3.92K 0.07% 127
2022
Q1
$362K Sell
2,828
-4
-0.1% -$438 0.1% 92
2021
Q4
$380K Buy
+2,832
New +$407K 0.11% 93

Other funds holding DXCM